Business Wire

PHENOM

5.5.2021 09:02:13 CEST | Business Wire | Press release

Share
Phenom Named Among First-Ever Strategic Leaders in Fosway’s 2021 9-Grid™ for Talent Acquisition

Phenom , the No. 1 provider of Talent Experience Management (TXM) solutions, has been recognized as a Strategic Leader in the 2021 Fosway 9-Grid™ for Talent Acquisition . Fosway identifies Strategic Leaders as companies that provide a rich suite of capability across a broad scope of features and have the sophistication to meet the needs of complex enterprise-scale customers. Additionally, these solutions achieve higher levels of customer impact and advocacy compared to alternatives in the market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210505005153/en/

The Fosway Group 9-Grid™ report for Talent Acquisition indicates the relative position of solutions and providers in the European talent acquisition system space. Analyzing data from the pandemic-altered market, the 2021 report also indicates how well software solutions scaled and performed for customers during last year’s volatility.

The report identified several key market and solution trends, including:

  • THE GREAT REBOARD: Companies that lost jobs last year are pivoting to better recruitment technology to prepare for strategic, efficient rehiring.
  • CANDIDATE EXPERIENCE: Transparent communication and agile decision-making underlie positive candidate experiences for both hires and non-hires.
  • ARTIFICIAL INTELLIGENCE: Enterprises must leverage AI and automation in the hiring process to remain competitive.
  • DIVERSITY, EQUITY & INCLUSION : Employers are realizing that diversity, equity and inclusion commitments must be a centerpiece in their HR strategies.
  • VIDEO EXPERIENCES : Live video’s role in hiring will last beyond the pandemic, as companies realize it will be an efficient, authentic way to find best-fit candidates.
  • INTERVIEW SCHEDULING : Chatbot and AI reduce friction across the scheduling process, generating more meaningful interactions between candidates and recruiters.
  • TALENT MARKETPLACE : The most effective solutions need to include gigs, reskilling and upskilling for mutual employer/employee growth.
  • COLLABORATIVE HIRING : Increasing communication between recruiter and hiring manager workflows is encouraged through integrations with Microsoft Teams and Slack.

“Phenom’s focus on disrupting the candidate and hiring experiences, has resonated strongly with the market,” said David Wilson, CEO of Fosway. “Rapid growth in adoption in enterprise organisations, as well as expanded physical presence and multiple market acquisitions is further accelerating its success in Europe and globally. All of these warrant Phenom’s increased rating as a Strategic Leader for Talent Acquisition in 2021.”

In 2020, the Phenom platform was adopted by 25,000 recruiters, talent marketers and hiring managers — helping them hire over 2 million people and engage over 3 million employees.

The Phenom platform automates administrative tasks and personalizes experiences, generating more impactful moments throughout the talent journey. As a result, candidates find the right job faster; employees learn and evolve; recruiters discover best-fit talent with efficiency and scale; and managers make stronger data-driven decisions to build their future teams.

Kuehne+Nagel, a global logistics company and Phenom customer, continues to see new value in the Phenom platform every day.

“Through Phenom, we’ve been able to strengthen our centralized recruitment activities per hemisphere, build an external career site and adapt it to local markets, implement a CRM — and now level up our employee experience — to build the most sophisticated talent acquisition ecosystem there is to offer,” said Sandra Aasma, global HR systems expert at Kuehne+Nagel.

“As Phenom continues to expand across EMEA, we’re honored to be one of the first-ever Strategic Leaders in Fosway’s Talent Acquisition grid,” said Jeff Carey, senior vice president of international business at Phenom. “Our new position on the Fosway 9-grid™ signals that enterprises routinely pick Phenom — galvanized by our sophisticated AI-powered platform and steadfast commitment to customers. By constantly upgrading and launching new products, we always stay at the front of a rapidly evolving HR technology market.”

Over 100 companies across the EMEA market have adopted Phenom’s platform to upgrade their talent experiences. As demand for Talent Experience Management has spiked, Phenom recently acquired two Europe-based companies and opened an office in Munich to complement its European headquarters in Rotterdam. With over 100 employees based in countries including Germany, France, Ireland, the Netherlands, Switzerland, Italy, Spain and the United Kingdom, Phenom continues to solidify EMEA’s importance within the company’s ultimate growth strategy.

To learn more about Phenom’s Strategic Leader position, please visit their blog .

To see Fosway’s full analysis, check out their 2021 9-grid™ .

About Phenom

Phenom is a global HR technology company with a purpose to help a billion people find the right job. With an expertise in building AI-powered, scalable solutions, Phenom Talent Experience Management (TXM) personalizes and automates the talent journey for candidates, recruiters, employees and management with its Career Site, Chatbot, CRM, CMS, SMS and Email Campaigns, University Recruiting, Internal Mobility, Career Pathing, Diversity & Inclusion, Talent Marketplace, Gigs, Referrals, Hiring Manager and Analytics. As a result, employers improve their talent acquisition and talent management efforts by helping candidates and employees find the right job, recruiters identify and engage the right talent, and management optimizes HR strategy, process and spend. Phenom was ranked among the fastest-growing technology companies in the 2020 Deloitte Technology Fast 500, and won a regional 2020 Timmy Award for launching and optimizing HelpOneBillion.com.

Headquartered in Greater Philadelphia, Phenom also has offices in India, Israel, the Netherlands, Germany and the United Kingdom.

For more information, please visit www.phenom.com . Connect with Phenom on LinkedIn , Twitter , Facebook , YouTube and Instagram .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye